Published “Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial” in The Lancet — cited 2,169 times.
- #crossref
- #research
- #work
Published “Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial” in The Lancet — cited 2,169 times.
Captured 2026-08-16 from Crossref. The archived copy is preserved so this citation survives link rot.